Top Back to top

HSCT experience in patients with Interferon gamma receptor deficiencies

Study number:
Type of transplant:
Short title:
Study status:
data collection open
Deadline for data collection:
Study design:
Primary objective:
Key inclusion criteria:
Inclusion criteria: only patients with a molecular diagnosis of IFNGR1/2 deficiency (including both complete and partial defects) AND treated with HSCT (including those patients who died during the procedure) will be eligible
Principal investigator:
Peter Olbrich
Principal investigator email:
EBMT Study coordinator:
Sheree Hazelaar & Henric-Jan Blok
Study coordinator email:

Need help?

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to